Trial intelligence / Profile preview

Evaluation of effect of chlorhexidine on prevention of ventilator-associated pneumonia

IRCT20180520039739N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of chlorhexidine in ventilator-associated pneumonia (VAP), sponsored by Isfahan University of Medical Sciences. Started Nov 2018; status: completed.

02

Drugs

chlorhexidine
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on IRCT20180520039739N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180520039739N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call